Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus

Rusch, Valerie W.; Parekh, Kalpaj R.; Leon, Larry; Venkatraman, Ennapadam; Bains, Manjit S.; Downey, Robert J.; Boland, Patrick J.; Bilsky, Mark H.; Ginsberg, Robert J.

doi:10.1067/mtc.2000.106089

Cited by 144 publications

(104 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…3 However, more aggressive forms of the disease with subclavian or spinal involvement (T4), as seen in this case, still remain a therapeutic challenge. While operative mortality is low at 4%, Rusch et al reported complete resection in only 64% of T3N0 and 39% of T4N0 patients, which was linked to an overall decreased 5-year survival of 46% and 13%, respectively.…”

Section: Discussionmentioning

confidence: 99%

En Bloc Resection of Pancoast Tumor with Adjuvant Aortic Endograft and Chemoradiation

Fischer

Marco³

et al. 2015

Methodist DeBakey Cardiovascular Journal

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

En Bloc Resection of Pancoast Tumor with Adjuvant Aortic Endograft and Chemoradiation

Fischer

Marco³

et al. 2015

Methodist DeBakey Cardiovascular Journal

View full text Add to dashboard Cite

“…In several studies, the pCR rate ranged between 16 and 36%. 11,28,36,37 In a previous publication, we showed that the overall survival was correlated to the pCR. 11 Previous studies have shown that the rate can be improved up to 40-47% by increasing the radiation dose.…”

Section: Discussionmentioning

confidence: 99%

Superior sulcus non-small cell lung carcinoma: A comparison of IMRT and 3D-RT dosimetry

Truntzer¹,

Antoni

Santelmo

et al. 2016

Reports of Practical Oncology & Radiotherapy

View full text Add to dashboard Cite

show abstract

Section: Treatmentmentioning

confidence: 99%

“…A mediastinoscopy should be performed, as N2 disease has been shown to be a poor prognostic factor [12][13][14][15]. Therefore, mediastinoscopy is mandatory and crucial in triaging those patients to the operative versus nonoperative approach.…”

Section: Diagnosis and Work-upmentioning

confidence: 99%

“…Vascular involvement and vertebral body involvement have historically been contraindications to surgical intervention; however, with advances in surgical techniques and better preoperative staging, tumors that were deemed unresectable may now undergo resection. Although technically feasible, the utility of surgery in the subset of patients with vertebral body and vascular invasion remains to be proven [14].Radiation therapy (RT) has been used as a single modality as well as in multimodality therapy. Monotherapy results are generally poor, however, and a 5-year survival rate of 23% has been reported [27,28].…”

mentioning

confidence: 99%

See 1 more Smart Citation

Superior Sulcus Tumors: A Mini-Review

Archie¹,

Thomas

2004

The Oncologist

View full text Add to dashboard Cite

The management and outcome for superior sulcus tumors have remained unchanged for 40 years. The rarity of these tumors has led to varying treatment techniques spanning decades, from which no solid conclusions can be drawn. Recent advances in combined-modality therapy have offered the first inkling that a paradigm shift is on the horizon. Here, we review the history and new advances in treating this challenging pulmonary neoplasm. The Oncologist 2004;9:550-555 The Oncologist 2004;9:550-555 www.TheOncologist.com Antonio, 7703 Floyd Curl Dr., San Antonio, Texas 78229, USA. Telephone: 210-616-5684; Fax: 210-949-5085; e-mail: cthomas@ctrc.net; Website: http://www.uthscsa.edu/radiationoncology Received January 27, 2004; accepted for publication May 10, 2004. ©AlphaMed Press 1083-7159/2004 In 1924, Pancoast [1] reported the clinical and radiographic findings associated with superior sulcus tumors. He initially thought that these tumors arose from epithelial rest cells from the fifth brachial cleft. Eight years later, Tobias [2] and Pancoast [3] simultaneously, correctly recognized that bronchogenic carcinoma was the primary cause of this syndrome. Correspondence: Charles R. Thomas Jr., M.D., Department of Radiation Oncology, University of Texas Health Science Center at San HISTORYSuperior sulcus tumors usually arise in the apex of the lung and may invade the second and third ribs, the brachial plexus, the subclavian vessels, the stellate ganglion, and adjacent vertebral bodies [4]. Pancoast syndrome is characterized by pain, which may arise in the shoulder or chest wall or radiate to the neck. Pain characteristically radiates to the ulnar surface of the hand. Horner's syndrome, which is composed of ptosis, meiosis, and anhydrosis, results from invasion of the paravertebral sympathetic chain. Weakness and atrophy of the hand and parasthesias are a common clinical finding resulting from invasion into the C8 and T1 roots of the brachial plexus. More infrequent manifestations include supraclavicular adenopathy, superior vena cava syndrome, and involvement of the phrenic or laryngeal nerves [5].Prior to the 1950s, superior sulcus tumors were uniformly fatal. Chardack and MacCallum [6] reported the The Oncologist ® Lung Cancer LEARNING OBJECTIVESAfter completing this course, the reader will be able to:1. Describe the diagnostic work-up for superior sulcus (Pancoast) tumors of the lung.2. List the major prognostic factors pertaining to outcome in patients with superior sulcus (Pancoast) tumors.3. Discuss the recent (SWOG 94-16) and current (SWOG-0220) intergroup trials for superior sulcus (Pancoast) tumors.Access and take the CME test online and receive 1 hour of AMA PRA category 1 credit at CME.TheOncologist.com CME CME by guest on May 9, 2018 http://theoncologist.alphamedpress.org/ Downloaded fromThis material is protected by U.S. Copyright law.Unauthorized reproduction is prohibited. For reprints contact: Reprints@AlphaMedPress.com first successful treatment with resection followed by postoperative radiation...

show abstract

Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus

Cited by 144 publications

References 25 publications

En Bloc Resection of Pancoast Tumor with Adjuvant Aortic Endograft and Chemoradiation

En Bloc Resection of Pancoast Tumor with Adjuvant Aortic Endograft and Chemoradiation

Superior sulcus non-small cell lung carcinoma: A comparison of IMRT and 3D-RT dosimetry

Superior Sulcus Tumors: A Mini-Review

Contact Info

Product

Resources

About